About Index Trending news
Analyze
Pricing
Armune BioScience

Armune BioScience

Work at Armune BioScience? Add yourself to this profile

Armune BioScience

Developed the technology APIFINY®—a prostate-cancer-specific non-PSA blood test that may improve decision making when selecting men for prostate biopsies.
Edit Profile
More info

Elsewhere

Companies in the same industry

Precision Biopsy Precision Biopsy Ovizio Ovizio Ceterix Orthopaedics Ceterix Orthopaedics Synedgen Synedgen Echometrix Echometrix CardioNXT CardioNXT Obalon Therapeutics Obalon Therapeutics BIOXIS Pharmaceuticals BIOXIS Pharmaceuticals Clinipace Worldwide Clinipace Worldwide Kineta, Inc Kineta, Inc

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 5
Add info
07 Sep 2016
$5,000,000
Venture capital (Series A)
Grand Angels Venture Fund II
Added by

Armune BioScience Closes $5M Series A Funding

FinSMEs
12 Jul 2016
$9,710,000
Venture capital (Series A)
Maverick Capital

Medical diagnostics startup secures $9M in funding

grbj
+2
20 Jan 2015
$3,537,583
Venture capital
22 Dec 2010
$250,000
Debt financing
25 Aug 2008
Venture capital